Clinical Trial Update: Twiist Postmarket Surveillance Study for Type 1 Diabetes

View source ↗

Summary

A postmarket surveillance clinical trial for Twiist in Type 1 diabetes mellitus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Twiist

Snippet

Sponsor: Deka Research and Development | Conditions: Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus | Status: RECRUITING